PAR 7.50% 21.5¢ paradigm biopharmaceuticals limited..

Sharewise Presentation 22/7/24, page-55

  1. 194 Posts.
    lightbulb Created with Sketch. 140
    mango - I am guessing I have spent more time on this than most but I am no expert.

    I haven't gone too much into the conversation around generics. at this point I've been more focused on is the science sound, do we have a viable company and can we get a deal. first things first

    as an example ... I am trying to get sas ipps. doctor 1 subscribes compounded pentosan as is a fan, he has never had an issues with this. I was literally in their office during a consultation showing them the 008 results and he was gobsmacked. he said if it dmoad it's a front line treatment and he would be prescribing this to patients at all stages of their oa / Injury journey and he would even prescribe it as a preventative remedy. ie u had a ligament tear in your knee, have this injection as it will prevent against future issues ... that type of thing.

    doctor 2 has pushed to get on the sas programme (he now is) and as a result of what he has seen has bought shares.

    all anecdotal clearly
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.